Paid Clinical Trials in Minnesota
Minnesota has 2,364 paid clinical trials enrolling now across cities including Rochester, Minneapolis and Saint Paul. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Research sites in Minnesota include Mayo Clinic and University of Minnesota Medical Center, running studies across oncology, cardiology, neurology, and more. The most actively recruiting conditions are Breast Cancer, Heart Failure, Malignant Solid Neoplasm, Endometrial Cancer — browse the full list or use the filters to match your diagnosis. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
2,364 clinical trials
↓ Download CSVMulti-Parametric MRI for Renal Transplantation
Transcranial Magnetic Stimulation for Adolescents and Young Adults With Cannabis Use Disorder
The Effect of Dry Needling With Electrical Stimulation on Individuals With Restless Legs Syndrome
Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary Complications
Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration
AVTX-801 D-galactose Supplementation in SLC35A2-CDG
Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers
Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
Technical Development of Multi-Parametric Renocerebral MRI
A Study for Cerebral Open Flow Microperfusion
Evaluating the Efficacy and Safety of D-galactose in PGM1-CDG (AVTX-801)
ICARE-LCS QUERI Partnered Evaluation Initiative: Integrating Comprehensive Tobacco Treatment to Enhance Lung Cancer Screening
The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans
Histoplasmosis Induction and Consolidation Therapy Factorial Randomized Clinical Trial (Histo-FACT)
Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders
Hand Perfusion and Pulse Oximetry Performance
Combating HIV Stigma in Healthcare Settings: A Standardized Patient Approach
Mechanisms of Resistance Exercise Training for Improved Muscle Insulin Sensitivity
HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization
A Study of Microcirculatory Function in Type 2 Myocardial Infarction (T2MI)
Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
An Insole and Ankle Device for Monitoring Cognitive Decline in Individuals at Risk for Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD)
H1ssF Flu Vaccine Clinical Trial
Meaning-Centered Psychotherapy for Addressing Existential Distress of Patient/Caregiver Dyads Following Hematopoietic Stem Cell Transplantation: Feasibility and Acceptability
Erector Spinae Plane Block Versus Trigger Point Injection for Chronic Thoracic Myofascial Pain
Synthetic THC And Blood Pressure
Menopausal Hormone Therapy And Left Ventricular Function
Exercise Cardiovascular Magnetic Resonance In Heart Failure With Preserved Ejection Fraction
A Study Comparing Shoulder Replacement Techniques For Patients With Shoulder Arthritis And An Intact Rotator Cuff
Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)
A Phase 1/2 Study of Safety and Tolerability of MT-125 With Chemoradiation in Patients With Newly Diagnosed MGMT Methylated Glioblastoma
Dorsal Root Ganglion Stimulation After Lower Motor Neuron Damage
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
SGLT2i Therapy in Islet Transplantation (SIT)
About research studies in Minnesota
Minnesota has approximately 2,364 recruiting research studies across a wide range of therapeutic areas. Minnesota is anchored by Mayo Clinic in Rochester and University of Minnesota Medical Center — nationally ranked for cancer, cardiology, and rare-disease research.
Common conditions studied in Minnesota
- Breast Cancer (34 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Heart Failure (32 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Malignant Solid Neoplasm (29 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Endometrial Cancer (24 active studies). Recruiting Endometrial Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Ovarian Cancer (24 active studies). Ovarian cancer research examines PARP inhibitors, maintenance therapies, and antibody-drug conjugates for recurrent and platinum-resistant disease.
- Multiple Myeloma (22 active studies). Recruiting Multiple Myeloma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Minnesota
- Mayo Clinic
- University of Minnesota
- National Cancer Institute (NCI)
- AstraZeneca
- Masonic Cancer Center, University of Minnesota
Local regulations and guidelines
Clinical trials in Minnesota are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Minnesota research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Minnesota. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Minnesota
Hipa.ai aggregates every recruiting study in Minnesota from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Minnesota?
There are approximately 2,364 recruiting clinical trials in Minnesota listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Minnesota pay participants?
Most recruiting trials in Minnesota compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Minnesota?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Minnesota?
The most common conditions under active study in Minnesota include Breast Cancer (34), Heart Failure (32), Malignant Solid Neoplasm (29), Endometrial Cancer (24), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Minnesota?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Minnesota on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Minnesota?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.